Nicola Clementi

3.9k total citations · 1 hit paper
80 papers, 1.9k citations indexed

About

Nicola Clementi is a scholar working on Epidemiology, Infectious Diseases and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Nicola Clementi has authored 80 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Epidemiology, 27 papers in Infectious Diseases and 18 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Nicola Clementi's work include SARS-CoV-2 and COVID-19 Research (18 papers), Monoclonal and Polyclonal Antibodies Research (18 papers) and Respiratory viral infections research (13 papers). Nicola Clementi is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (18 papers), Monoclonal and Polyclonal Antibodies Research (18 papers) and Respiratory viral infections research (13 papers). Nicola Clementi collaborates with scholars based in Italy, United States and United Kingdom. Nicola Clementi's co-authors include Nicasio Mancini, Massimo Clementi, Roberto Burioni, Elena Criscuolo, Roberta A. Diotti, Matteo Castelli, Giuseppe A. Sautto, Sreya Ghosh, Ivan Zanoni and Maria De Santis and has published in prestigious journals such as Science, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Nicola Clementi

73 papers receiving 1.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Type III interferons disrupt the lung epithelial barrier upon viral recognition

2020 258 citations Achille Broggi, Sreya Ghosh et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicola Clementi Italy	26	714	650	411	409	306	80	1.9k
Fei Yu China	26	1.7k 2.4×	862 1.3×	228 0.6×	578 1.4×	282 0.9×	83	2.8k
Nicasio Mancini Italy	31	1.1k 1.6×	1.2k 1.9×	458 1.1×	632 1.5×	562 1.8×	123	3.3k
Yan Guo China	27	944 1.3×	380 0.6×	446 1.1×	735 1.8×	116 0.4×	67	2.0k
Adalbert Krawczyk Germany	25	933 1.3×	942 1.4×	273 0.7×	253 0.6×	114 0.4×	75	2.4k
John C. Tilton United States	22	969 1.4×	468 0.7×	907 2.2×	507 1.2×	138 0.5×	35	2.4k
Christiane S. Eberhardt Switzerland	25	873 1.2×	595 0.9×	606 1.5×	312 0.8×	75 0.2×	55	2.2k
Anne Goffard France	19	897 1.3×	676 1.0×	192 0.5×	236 0.6×	289 0.9×	49	2.0k
Gianpiero D’Offizi Italy	27	757 1.1×	758 1.2×	657 1.6×	300 0.7×	64 0.2×	127	2.4k
Arno C. Andeweg Netherlands	27	951 1.3×	841 1.3×	608 1.5×	345 0.8×	64 0.2×	54	2.1k
Jieliang Chen China	20	757 1.1×	1.2k 1.8×	558 1.4×	985 2.4×	120 0.4×	44	2.6k

Countries citing papers authored by Nicola Clementi

Since Specialization

Citations

This map shows the geographic impact of Nicola Clementi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicola Clementi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicola Clementi more than expected).

Fields of papers citing papers by Nicola Clementi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicola Clementi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicola Clementi. The network helps show where Nicola Clementi may publish in the future.

Co-authorship network of co-authors of Nicola Clementi

This figure shows the co-authorship network connecting the top 25 collaborators of Nicola Clementi. A scholar is included among the top collaborators of Nicola Clementi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicola Clementi. Nicola Clementi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rossi, Elena, Silvia Marenna, Valerio Castoldi, et al.. (2025). Tracking remyelination in a model of multiple sclerosis: Visual evoked potentials reveal therapeutic effect from brain stimulation and exercise. Experimental Neurology. 397. 115565–115565.

Zordan, Paola, Matteo Grioni, Anna Tosi, et al.. (2025). Microbiome modulation uncouples efficacy and toxicity induced by immune checkpoint blockade in mouse multiple myeloma. Nature Communications. 16(1). 10384–10384.

Ferrarese, Roberto, Federica Novazzi, Gabriele Arcari, et al.. (2025). Expression Patterns of Interferons and Proinflammatory Cytokines in the Upper Respiratory Tract of Patients Infected by Different Viral Pathogens: Correlation with Age and Viral Load. Biomolecules. 15(11). 1545–1545.

Raccagni, Angelo Roberto, Laura Galli, Martina Ranzenigo, et al.. (2024). Trends of Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates Between 2012 and 2023: Results From an Open Italian Cohort. Sexually Transmitted Diseases. 51(8). 540–544. 4 indexed citations

Criscuolo, Elena, Matteo Castelli, Roberto Burioni, et al.. (2024). Single spike mutation differentiating XBB.1 and XBB.1.5 enhances SARS-CoV-2 cell-to-cell transmission and facilitates serum-mediated enhancement. Frontiers in Immunology. 15. 1501200–1501200. 1 indexed citations

Lai, Michele, A. De Carli, Pietro Giorgio Spezia, et al.. (2023). Inhibiting immunoregulatory amidase NAAA blocks ZIKV maturation in Human Neural Stem Cells. Antiviral Research. 216. 105664–105664. 2 indexed citations

Mori, Mattia, Deborah Quaglio, Andrea Calcaterra, et al.. (2023). Natural Flavonoid Derivatives Have Pan-Coronavirus Antiviral Activity. Microorganisms. 11(2). 314–314. 11 indexed citations

Messina, Emanuela, Angelo Roberto Raccagni, Nicola Clementi, et al.. (2023). A case of breakthrough mpox infection in an individual non-responder to MVA-BN vaccination. The Lancet Infectious Diseases. 24(1). e11–e12. 1 indexed citations

Criscuolo, Elena, Roberto Ferrarese, Davide Ferrari, et al.. (2023). Smallpox vaccination‐elicited antibodies cross‐neutralize 2022‐Monkeypox virus Clade II. Journal of Medical Virology. 95(3). e28643–e28643. 14 indexed citations

10.

Spagnuolo, Vincenzo, Laura Galli, Andrea Poli, et al.. (2022). Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study. Drug Design Development and Therapy. Volume 16. 3645–3654. 3 indexed citations

11.

Velázquez‐Moctezuma, Rodrigo, Matteo Castelli, Nicola Clementi, et al.. (2021). Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies. Vaccines. 9(3). 291–291. 12 indexed citations

12.

Severa, Martina, Roberta A. Diotti, Marilena P. Etna, et al.. (2021). Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection. PLoS Pathogens. 17(9). e1009878–e1009878. 59 indexed citations

13.

Ferrari, Davide, Nicola Clementi, Elena Criscuolo, et al.. (2021). Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine. Vaccines. 9(11). 1357–1357. 24 indexed citations

14.

Castelli, Matteo, Andreina Baj, Elena Criscuolo, et al.. (2021). Characterization of a Lineage C.36 SARS-CoV-2 Isolate with Reduced Susceptibility to Neutralization Circulating in Lombardy, Italy. Viruses. 13(8). 1514–1514. 9 indexed citations

15.

Broggi, Achille, Sreya Ghosh, Benedetta Sposito, et al.. (2020). Type III interferons disrupt the lung epithelial barrier upon viral recognition. Science. 369(6504). 706–712. 258 indexed citations breakdown →

16.

Lai, Alessia, Annalisa Bergna, Nicola Clementi, et al.. (2020). Molecular Tracing of SARS-CoV-2 in Italy in the First Three Months of the Epidemic. Viruses. 12(8). 798–798. 37 indexed citations

17.

Clementi, Nicola, Elena Criscuolo, Matteo Castelli, et al.. (2017). Role and potential therapeutic use of antibodies against herpetic infections. Clinical Microbiology and Infection. 23(6). 381–386. 11 indexed citations

18.

Sautto, Giuseppe A., Karin Wisskirchen, Nicola Clementi, et al.. (2015). Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein. Gut. 65(3). 512–523. 71 indexed citations

19.

Marco, Donata De, Nicola Clementi, Nicasio Mancini, et al.. (2012). A Non-VH1-69 Heterosubtypic Neutralizing Human Monoclonal Antibody Protects Mice against H1N1 and H5N1 Viruses. PLoS ONE. 7(4). e34415–e34415. 44 indexed citations

20.

Burioni, Roberto, Filippo Canducci, Nicasio Mancini, et al.. (2010). Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV). Virology. 399(1). 144–152. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact